Market Overview

Vetr Upgrades Juno To Buy Amid Volatile May


The Vetr crowd on Monday upgraded its rating for Juno Therapeutics Inc (NASDAQ: JUNO) from 4 stars, issued two days ago, to 5 stars. Crowd sentiment at the time of the upgrade was mostly positive, with 87 percent of Vetr user ratings bullish.

Price in the oncology-centered biotech company has been extremely active throughout the month of May, spiking and correcting rapidly by as much as 15 percent several times over the month. The first correction that dropped the stock about $3.50 followed a mixed earnings report on May 4 that showed higher-than-expected sales, but EPS that matched low expectations. The stock quickly rebounded and surpassed its per-earnings price, rising above $26 by mid-May. Still, stock has receded somewhat since then, closing Monday at $24.07.

Learn how crowdsourced ratings could help you time the market.

Currently, the Vetr crowd's average target price for Juno is up at $27.94, which is still below the average analyst target price of $34.50. Less than 2 percent of Vetr users are holding JUNO in their watch lists.

Latest Ratings for JUNO

Jan 2018Standpoint ResearchDowngradesBuyHold
Jan 2018BarclaysDowngradesOverweightEqual-Weight
Jan 2018Maxim GroupDowngradesBuyHold

View More Analyst Ratings for JUNO
View the Latest Analyst Ratings


Related Articles (JUNO)

View Comments and Join the Discussion!

Posted-In: VetrUpgrades Price Target Crowdsourcing Analyst Ratings

Latest Ratings

MRUTD SecuritiesMaintains62.0
BYDTD SecuritiesMaintains245.0
AIFTD SecuritiesMaintains50.0
MTNBAegis CapitalMaintains3.5
FSKRWells FargoMaintains14.8
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at